Policy Analysis: Investment, Life Sciences
Published:

Harmonise clinical trial regulations to boost medical research - and save lives

Complex and inconsistent clinical trial regulations are causing delays and raising costs for academic clinicians conducting international studies. Governments need to harmonise trial approval processes, says the OECD

Frédéric Sgard, Project Administrator, OECD Global Science Forum

Clinical trials are an essential part of the development of medical treatments. They involve  testing new medicines or new therapies, as well as optimising existing medicinal products and procedures, by carrying out carefully controlled investigations on patients. Although the majority of these trials are conducted by the pharmaceutical industry, many are driven by pressing public health needs, and by scientific opportunities, rather than by economic interests of private companies.

Such trials often involve diseases that affect...



Related subjects: clinical diagnostics

The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
Barcelona - 20 November 2015
The future of manufacturing: Industry 4.0 (Date to be confirmed)
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 29 September 2015
Views of 2030: Transport, manufacturing, education and health
In October 2014, members of the Science|Business Network of universities and companies met in Berlin to compare notes about the future of four key sectors in Europe. This is what they see coming.